Fig. 5

MeCP2 knockdown inhibited glioma cell EMT phenotype in vivo. a Size of tumors were measured every 7 days after injection. **p < 0.01 vs. sh-con. b Expression of ZEB1 and ZEB2 by staining immunohistochemical (IHC) in subcutaneous tumors of mice injected with sh-con or sh-MeCP2 cells. c The ZEB1-expressing cells and the ZEB2-expressing cells were qualified. **p < 0.01 vs. sh-con